Notice of Proposed Sale · 144
CG Oncology, Inc.
CGONNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- CG Oncology, Inc.
- Issuer CIK
- 0001991792
- SEC file number
- 001-41925
- Phone
- 9494093700
- Person for whose account securities are to be sold
- LEONARD POST
- Relationships to issuer
- Director
- Street
- 3000 Pegasus Park Drive, Suite 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 3,000 | 185,520.00 | 88,640,375 | 10/15/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 10/15/2026 | Exercise of Stock Options | Issuer | 3,000 | N | 10/15/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for LEONARD POST | Common | 09/15/2026 | 1,000 | 72,982.80 |
| 10b5-1 Sales for LEONARD POST | Common | 08/14/2026 | 1,000 | 74,540.00 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for LEONARD POST
- Street
- 3000 Pegasus Park Drive, Suite 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Seller — prior-sale row 2, entry 1
- Name
- 10b5-1 Sales for LEONARD POST
- Street
- 3000 Pegasus Park Drive, Suite 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Notice signature
- Notice date
- 10/15/2026
- Signed
- /s/ Leonard Post
- Plan adoption dates
- 03/05/2026
Company context
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.